X-Factor™ Reduces Inflammatory Marker
Study suggests arachidonic acid may offer health-protecting benefit to exercising individuals.
June 17, 2006: Jupiter, FL.
Researchers at the Exercise & Sports Nutrition Laboratory in Baylor University have concluded their preliminary studies into the effects of arachidonic acid (AA) supplementation (X-Factor™, Molecular Nutrition) on resistance-trained males. Their results were presented at the International Society of Sports Nutrition (ISSN) conference this past weekend in Las Vegas Nevada. One facet of this study looked at the effects of AA supplementation on Interleukin-6 (IL-6), a primary regulator of inflammation in the body. Analysis of the data showed that the X-factor group noticed a trend towards significant reductions in serum IL-6 after 50 days of supplementation.
In addition to being a central regulator of inflammation, Interleukin-6 (IL-6) is the primary stimulus for the hepatic production of C-reactive protein. IL-6 is associated with a number of adverse health conditions including cardiovascular disease, diabetes, autoimmune disorder, rheumatoid arthritis, asthma, osteoporosis and cancer. IL-6 is used as a primary serum marker of inflammation, and is an independent predictor of mortality in a number of serious illnesses. A decrease in serum IL-6 may represent a protective effect against systemic inflammation.
.